Agilent Technologies gets 2017 Scientists' Choice Award for Best Webinar Series

Agilent Technologies Inc. (NYSE: A) has received a 2017 Scientists´ Choice Award — Best Webinar Series of the Year — for its Biopharmaceuticals Webinar Series titled Solutions in Biopharmaceutical Discovery and Development, which ran for 10 episodes over the course of 2016, the company said.

The award recognizes excellence in online scientific communication.

SelectScience announced the winners of the 2017 Scientists´ Choice Awards during a special ceremony held on March 7 at the Pittcon 2017 International Conference and Expo in Chicago, IL.

The 10- session series includes the following webinars:

Rapidly Characterize Antibody-Drug Conjugates and Derive Drug-to-Antibody
Ratios Using LC/MS.
Biosimilars Workflow: Biocolumns.
Three-Part Series: Technology Accelerating Biopharma: Analytical Workflow Solutions.
Online 2D-LC Analysis of Complex N-Glycans in Biopharmaceuticals.
Enhancing the Mass Spectrometry Characterization of Antibody Drug
Conjugates (ADCs).
New Advances in Biotherapeutic Aggregate and Charge Variant Analysis.
Faster Aggregation Method Development with Cutting Edge LC Technology.
Rapid, Powerful Technologies to Address Peptide Mapping Challenges
— A Comprehensive Workflow Solution from Sample to Answer.
About Agilent Technologies

Agilent Technologies, a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world.